EMPLOYEE PRIVACY | 2026-11-01
Off-Duty Cannabis Use Rights Under AB 2188 in California: 2026
How Government Code section 12954 protects California workers from discrimination for legal, off-the-job cannabis use and outdated drug tests.
By Anatolii Trembach, Esq. (California State Bar No. 349304; LL.M., USC Gould School of Law; admitted to the U.S. Court of International Trade), Trembach Law Firm, APC · Published
Cannabis has been legal for adult recreational use in California since 2016, yet for years workers could still be fired or refused a job based on a drug test that detected cannabis they had used days earlier, off duty and off site. Assembly Bill 2188 closed that gap. Effective January 1, 2024, Calif
What AB 2188 Changed for California Workers
Assembly Bill 2188 added Gov. Code § 12954 to the Fair Employment and Housing Act (FEHA). Operative January 1, 2024, the statute makes it unlawful for an employer to discriminate against a person in hiring, termination, or any term or condition of employment because of two things: the person's use of cannabis off the job and away from the workplace, and an employer-required drug screening test that found the person to have nonpsychoactive cannabis metabolites in their hair, blood, urine, or other bodily fluids.
This two-part structure is the heart of the law. California recognized that most conventional cannabis drug tests do not measure current impairment at all. They detect metabolites, the inactive byproducts that linger in the body for days or weeks after the psychoactive effects have worn off. A positive metabolite result therefore tells an employer nothing about whether the worker is impaired on the job; it reveals only that the person used cannabis at some earlier point, likely on their own time. AB 2188 says that kind of result can no longer be a lawful basis for an adverse decision.
The Difference Between Metabolites and Impairment
Understanding AB 2188 requires understanding the science the Legislature relied on. When a person consumes cannabis, the psychoactive compound produces impairment for a limited window. After that, the body breaks the compound down into nonpsychoactive metabolites that do not cause impairment but can remain detectable for a long time. A standard urine or hair test screens for these metabolites, not for active impairment.
Because of this, Gov. Code § 12954 targets tests that screen for nonpsychoactive metabolites. The statute does not force employers to tolerate on-the-job impairment, and it does not bar all testing. Employers remain free to use scientifically valid testing methods that identify the active presence of cannabis, which can indicate recent use and possible impairment, rather than the inert metabolites that merely show past use. The law thus channels employers toward testing that actually measures the workplace concern, current impairment, instead of punishing lawful private conduct.
What AB 2188 Does Not Prohibit
AB 2188 preserves important employer rights. The statute does not permit an employee to possess, to be impaired by, or to use cannabis on the job. An employer may still maintain a drug-free and impairment-free workplace and may discipline a worker who is impaired at work or who uses or possesses cannabis during work hours or on the premises.
The law also does not preempt the employer's ability to conduct lawful pre-employment or other drug testing using methods that do not rely on nonpsychoactive metabolites. For example, testing that detects the active psychoactive compound, which correlates with recent use, remains available. The point of Gov. Code § 12954 is narrow but powerful: it stops employers from treating evidence of past, off-duty, legal use, in the form of lingering metabolites, as grounds for an adverse employment action.
The Key Exemptions Under the Statute
Not every worker is covered. AB 2188 carves out significant exemptions. The protections do not apply to employees in the building and construction trades. They also do not apply to applicants or employees hired for positions that require a federal government background investigation or security clearance in accordance with federal regulations.
In addition, the statute does not preempt state or federal laws that require applicants or employees to be tested for controlled substances as a condition of employment, of receiving federal funding or federal licensing-related benefits, or of entering into a federal contract. These exemptions reflect the reality that some positions are governed by overriding federal requirements, such as those affecting certain transportation and safety-sensitive roles. Workers in exempt categories should not assume AB 2188 shields them, and employers should confirm whether a specific federal mandate applies before relying on an exemption.
SB 700 and the Ban on Asking About Prior Cannabis Use
California reinforced AB 2188 with Senate Bill 700 in 2023, which took effect alongside the cannabis protections. SB 700 amended FEHA to make it unlawful for an employer to request information from an applicant about the applicant's prior use of cannabis. In other words, an employer generally cannot ask a job candidate whether, or how, they have used cannabis in the past.
There is a coordinating provision: information about prior cannabis use obtained from an applicant's criminal history may be considered only where the employer is permitted to consider or inquire about that history under other provisions of state or federal law. Together, AB 2188 and SB 700 form a two-sided shield. AB 2188 stops employers from punishing off-duty use revealed by metabolite testing, and SB 700 stops them from fishing for past-use information during hiring. For California workers in 2026, these laws significantly expand privacy around lawful cannabis use.
How Off-Duty Cannabis Protections Fit Within FEHA
Because AB 2188 placed these protections in FEHA through Gov. Code § 12954, a violation is treated as an unlawful employment practice, like other forms of discrimination the statute prohibits under Gov. Code § 12940. That placement is deliberate and consequential. It means a worker who is refused a job or terminated because of a metabolite-based test or lawful off-duty use can pursue the claim through California's established civil rights enforcement system.
It also means the anti-retaliation principles that run throughout FEHA apply. An employer that punishes a worker for objecting to an unlawful metabolite test, or for asserting rights under the cannabis provisions, risks a retaliation claim in addition to the underlying discrimination claim. Employee privacy in California increasingly rests on this FEHA foundation, a theme that recurs across our employment law news coverage.
Enforcing Your Rights: Deadlines and Remedies
A worker who believes an employer violated AB 2188 or SB 700 generally enforces the claim through the California Civil Rights Department (CRD). The worker files an administrative complaint under Gov. Code § 12960, which generally allows three years from the unlawful act, and after receiving a right-to-sue notice typically has one year to file a civil action.
Available remedies track those for other FEHA violations and can include instatement or reinstatement, back pay and front pay, emotional-distress damages, injunctive relief, attorney's fees, and, in cases involving malice, oppression, or fraud, punitive damages. Because these cases often hinge on the type of drug test used and the timing of the adverse action, preserving the test documentation, the job offer or termination paperwork, and any communications about cannabis is essential. The background-check context raises parallel privacy issues; see our discussion of background check reports under the ICRAA for how California polices the information employers gather about applicants.
Practical Steps for Workers and Employers
If you are a worker or applicant, keep records of any drug test an employer required, including what kind of test it was and when you last used cannabis relative to the test. If a job offer is withdrawn or you are fired after a positive result, document the stated reason and the timing. Do not assume you are covered if you work in construction or a federally regulated safety-sensitive role, but do consult counsel, because the exemptions are narrower than many employers assume.
If you are an employer, audit your testing program to ensure you are not relying on nonpsychoactive-metabolite results to make hiring or discipline decisions for covered workers, remove questions about prior cannabis use from applications and interviews to comply with SB 700, and confirm any claimed exemption is grounded in an actual federal requirement. Training hiring managers on Gov. Code § 12954 is the simplest way to avoid liability.
The Science Behind the Legislature's Approach
AB 2188 is unusual among employment statutes in that its logic rests explicitly on toxicology. The Legislature found that tetrahydrocannabinol, the psychoactive compound in cannabis, is stored in the body as nonpsychoactive metabolites after use and that these metabolites remain detectable long after any impairing effect has ended. A urine or hair follicle test that screens for these metabolites can return a positive result weeks after a single off-duty use, when the worker has long since returned to full sobriety.
This scientific reality is why Gov. Code § 12954 draws the line precisely where it does. The statute does not say employers must tolerate impaired workers; it says employers may not rely on a test that detects only the inert aftermath of past use. Newer testing technologies can measure the active psychoactive compound, which correlates with recent consumption and potential current impairment. By steering employers toward impairment-relevant testing, California aligned drug policy with the actual workplace concern. For workers, the practical takeaway is that the type of test an employer used is often the decisive fact in a claim, so identifying whether a test screened for metabolites or active compounds is an essential early step.
How AB 2188 Interacts With the Legalization Framework
AB 2188 did not legalize cannabis; adult-use legalization arrived earlier through voter initiative, and cannabis remains comprehensively regulated under California law. What AB 2188 did was close the gap between legal off-duty conduct and employment consequences. For years, a worker could lawfully consume cannabis on a weekend yet be fired on Monday for a positive metabolite test, a result many Californians found inconsistent with legalization. The statute resolved that tension in favor of the worker for most private-sector positions.
Cannabis nonetheless remains illegal under federal law, which is why the exemptions in Gov. Code § 12954 for federally regulated positions and federal-contract or federal-funding conditions are so important. Those exemptions acknowledge that an employer bound by federal drug-testing mandates cannot be forced by state law to violate them. The result is a layered landscape: broad state protection for most workers, with carve-outs where federal law governs. Workers and employers alike must identify which layer applies before assessing rights, because the same off-duty conduct can be protected in one role and unprotected in another.
What Employers May Still Do to Manage Impairment
A frequent misconception is that AB 2188 strips employers of all authority over cannabis. It does not. Employers retain the right to prohibit possession, use, and impairment during work hours and on the premises, and may act on reasonable, individualized evidence that a worker is impaired on the job. Nothing in Gov. Code § 12954 requires an employer to accommodate an employee who is actually under the influence while working, particularly in safety-sensitive settings.
Employers may also continue reasonable, lawful testing that does not rely on nonpsychoactive metabolites. Observation-based impairment protocols, where trained supervisors document specific signs of impairment and the employer follows a consistent, nondiscriminatory process, remain available. The key compliance principle is to separate legitimate impairment management from the prohibited use of metabolite results to punish lawful off-duty conduct. Employers that document a clear, impairment-focused policy and apply it evenhandedly are well positioned to defend their decisions, while those that cling to metabolite-based screening for covered workers invite liability.
Applicants and the Hiring Process Under AB 2188 and SB 700
The hiring stage is where AB 2188 and SB 700 work together most visibly. Under AB 2188, an employer generally cannot refuse to hire a qualified applicant based on a metabolite-detecting drug test. Under SB 700, the employer generally cannot ask the applicant about prior cannabis use at all. Together, these provisions reshape the pre-employment screening process for covered positions.
Applicants should be alert to application questions, interview inquiries, and conditional-offer testing that probe past cannabis use or rely on metabolite screening. If a conditional offer is withdrawn after a positive metabolite test, or if an interviewer asks about prior cannabis use and the applicant is then rejected, the timing and content of those interactions become important evidence. The background-screening context raises adjacent privacy and accuracy concerns under California's consumer reporting laws; our analysis of background check reports under the ICRAA explains how employers must handle the information they gather about applicants. Applicants who document the hiring process preserve their ability to challenge an unlawful rejection.
Building and Proving an AB 2188 Claim
A successful claim under Gov. Code § 12954 generally rests on three facts: that the worker is in a covered position rather than an exempt one, that the employer took an adverse action such as rescinding an offer or terminating employment, and that the action was based on off-duty cannabis use or a metabolite-detecting test rather than on-the-job impairment. The worker should gather the drug-test documentation to establish what the test actually measured, since a metabolite screen is strong evidence that the prohibited basis was used.
The worker should also preserve the offer letter or termination notice, any policy documents describing the testing program, and communications referencing the positive result. Where the employer claims an exemption, the worker can probe whether a genuine federal requirement actually applies, because employers sometimes assert exemptions that do not fit the position. Claims proceed through the Civil Rights Department under Gov. Code § 12960, and the available FEHA remedies give these claims real value. Because the statute is still relatively new, developments continue to emerge, and workers benefit from prompt legal advice to position a claim correctly.
Multistate Employers and California Workers
Many Californians work for companies headquartered elsewhere, and those employers sometimes apply a uniform national drug-testing policy that does not account for California's protections. A policy that automatically rejects any applicant with a positive metabolite screen may be lawful in some states but unlawful as applied to covered California workers under Gov. Code § 12954. The location of the worker, not the location of the corporate headquarters, generally determines which protections apply, so a California employee is entitled to the statute's protections even if the employer's handbook was written for a different jurisdiction.
This mismatch is a frequent source of violations. A national human resources team may not realize that California prohibits reliance on nonpsychoactive metabolite results and bars pre-hire questions about prior cannabis use under SB 700. Workers who encounter a nationwide policy that conflicts with California law should not assume the policy is valid simply because it is applied company-wide. The conflict is often resolved in the worker's favor, and documenting how the national policy was applied to a California position helps establish the claim. Employers operating across state lines should maintain a California-specific addendum to their testing and hiring policies to avoid this exposure.
How AB 2188 Fits the Arc of California Employee Privacy Law
AB 2188 is part of a broader California trend toward protecting workers' off-duty conduct and personal privacy. California has long restricted employers from disciplining workers for lawful off-duty activities, and the cannabis protections extend that tradition to a substance that, while legal under state law, had remained a basis for adverse employment action. By placing the protection inside FEHA at Gov. Code § 12954, the Legislature signaled that off-duty cannabis use is a matter of civil rights, not merely workplace policy.
This framing has consequences for how claims are litigated and valued. FEHA's remedial scheme, its anti-retaliation principles, and its administrative enforcement through the Civil Rights Department under Gov. Code § 12960 all now apply to cannabis-related employment decisions for covered workers. As testing technology evolves toward impairment-based measures and as more employers update their policies, the number of positions where metabolite screening can lawfully drive decisions is shrinking. For California workers, AB 2188 represents a durable expansion of privacy that is likely to grow more significant over time, not less.
Frequently Asked Questions
Can my employer fire me for using cannabis on my day off?
Generally no, if you are a covered worker. Under Gov. Code § 12954, effective January 1, 2024, it is unlawful to discriminate based on cannabis use off the job and away from the workplace, or based on a test detecting nonpsychoactive metabolites. The law does not protect on-the-job use or impairment.
Does AB 2188 ban all cannabis drug testing?
No. It targets tests that screen for nonpsychoactive metabolites, which show only past use, not current impairment. Employers may still use scientifically valid methods that detect active cannabis compounds indicating recent use, and may bar impairment at work.
Who is exempt from AB 2188?
Employees in the building and construction trades are exempt, as are positions requiring a federal background investigation or security clearance. The law also does not override state or federal rules that mandate drug testing as a condition of employment, funding, licensing, or a federal contract.
Can an employer ask about my past cannabis use in an interview?
Generally no. Senate Bill 700, effective in 2024, made it unlawful under FEHA for an employer to ask an applicant about prior cannabis use, with a narrow coordination for criminal-history information the employer is otherwise permitted to consider.
What can I recover if my employer violated these laws?
Because the protections sit in FEHA, remedies can include reinstatement, back pay, emotional-distress damages, injunctive relief, attorney's fees, and potentially punitive damages. Claims generally begin with a complaint to the Civil Rights Department under Gov. Code § 12960.
If you lost a job offer or were fired because of a cannabis drug test or lawful off-duty use, or an employer asked about your past cannabis use, you may have a claim under Gov. Code § 12954 and SB 700. Trembach Law Firm helps California workers enforce these privacy protections and advises employers on compliant testing programs. Call Trembach Law Firm at (213) 645-2246 for a confidential consultation.
Contact Trembach Law Firm at (818) 514-7680 for a confidential consultation.
Trembach Law Firm | 27001 Agoura Road, Suite 350, Calabasas, CA 91301